Sale! View larger

ASTM D4774-11(2017)

New product

ASTM D4774-11(2017) Standard Specification for User Applied Drug Labels in Anesthesiology

standard by ASTM International, 12/15/2017

More details

$17.63

-57%

$41.00

More info

Full Description

1.1This specification covers the size, color, pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content. This specification is not intended to cover labels applied by the drug manufacturer.

FIG. 1Standard Background Colors for User Applied Syringe Drug Labels

Standard Background Colors for User Applied Syringe Drug LabelsStandard Background Colors for User Applied Syringe Drug Labels

FIG. 2 Label for an Antagonist Drug

Label for an Antagonist DrugLabel for an Antagonist Drug

FIG. 3 Reversed Plate Printing Used to Identify "SUCCINYLcholine," "EPINEPHrine," and Beta Blockers, "ESMOlol," "LABATolol," and "METOprolol"

Reversed Plate Printing Used to Identify SUCCINYLcholine, EPINEPHrine, and Beta Blockers, ESMOlol, LABATolol, and METOprololReversed Plate Printing Used to Identify SUCCINYLcholine, EPINEPHrine, and Beta Blockers, ESMOlol, LABATolol, and METOprolol

FIG. 4Optional Printing

Optional PrintingOptional Printing

Note-Bold upper-case type is shown for first or first and second syllables of the drug name.

FIG. 5 Drug Name and Dosage

Drug Name and DosageDrug Name and Dosage

FIG. 6 Alternative Label Showing Concentration in Percent and mg/mL

Alternative Label Showing Concentration in Percent and mg/mLAlternative Label Showing Concentration in Percent and mg/mL

1.2The values stated in SI units are to be regarded as the recommended values. The use of inch-pound system values, not being exact equivalents, may result in nonconformance with the standard.

1.3This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.4This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

Product Details

Published: 12/15/2017 Number of Pages: 3File Size: 1 file , 330 KB